NEW YORK (GenomeWeb News) - Genomatix said yesterday that Sanofi-Aventis has renewed its multi-site license for its Microarray Analysis Pipeline software.
The software analyzes data for a number of micorarray applications, including gene expression, tiling microarrays, and ChIP-on-chip studies.
Sanofi-Aventis originally licensed the company’s GenomatixSuite software in 2005.
Financial terms of the agreement were not released.